This site is intended for healthcare professionals
Magnifying glass on blue background; searching for results

Find disease awareness content and relevant supporting materials

Learning Zone 508 Events 5 News 20323 Drugs 42717 Trials 863 Guidelines 631 Journals 1966
Filter results
Sort by:
Relevance
to
Blue test tubes arranged in a line, disappearing into the background
News
28/05/25

Update provided on phase II clinical trial of RP A501 for Danon disease - Rocket Pharmaceuticals

  • 2 min read
Blue test tubes arranged in a line, disappearing into the background
News
28/05/25

CHMP adopts a positive opinion for Rolcya (denosumab biosimilar)

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
News
28/05/25

FDA approves Yutrepia (treprostinil) inhalation powder for patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) - Liquidia

  • 2 min read
Latest industry news
News
25/05/25

Regeneron acquires the assets of 23andMe Holding Co.

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
News
25/05/25

FDA approves the supplemental NDA for Zoryve (roflumilast) topical foam 0.3% for the treatment of plaque psoriasis of the scalp and body in adult and pediatric patients.- Arcutis Biotherapeutics

  • 2 min read
Blue test tubes arranged in a line, disappearing into the background
News
24/05/25

Xtandi (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer - Astellas and Pfizer

  • 4 min read
Blue test tubes arranged in a line, disappearing into the background
News
29/05/25

Moderna files FDA application for the LP.8.1 targeting Covid-19 Vaccine

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
News
28/05/25

CHMP positive opinion for Bomyntra, and Conexxence biosimilars for the treatment of osteoporosis and other bone-related conditions- Fresenius Kabi

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
News
28/05/25

The phase III AFFIRM-AL clinical trial evaluating birtamimab in patients with AL amyloidosis did not meet its primary endpoint.- Prothena Corporation

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
News
28/05/25

Imfinzi (durvalumab) recommended for approval in the EU by CHMP as first and only perioperative immunotherapy for muscle-invasive bladder cancer- AstraZeneca

  • 2 min read
See more